Pharmacoeconomic study of tacrolimus-based versus cyclosporine-based immunosuppressive therapy following liver transplantation.
Rabkin
J M
JM
Department of Surgery, Section of Liver Transplantation, Oregon Health Sciences University and Portland Veterans Affairs Medical Center, Portland, Oregon, USA.
Corless
C L
CL
Rosen
H R
HR
Olyaei
A J
AJ
D000208:Acute Disease; D001379:Azathioprine / Q000008:administration & dosage; D001706:Biopsy; D016572:Cyclosporine / Q000009:adverse effects / Q000191:economics*; D005260:Female; D006084:Graft Rejection / Q000191:economics* / Q000517:prevention & control; D006526:Hepatitis C / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000191:economics*; D007902:Length of Stay; D016031:Liver Transplantation / Q000191:economics* / Q000401:mortality / Q000473:pathology; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D011446:Prospective Studies; D012008:Recurrence; D016559:Tacrolimus / Q000009:adverse effects / Q000191:economics*
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone; D016559:Tacrolimus; D008775:Methylprednisolone